LPL Financial
CADL icon

LPL Financial’s Candel Therapeutics CADL Stock Holding History

LPL Financial’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$404K Buy
39,227
+14,525
+59% +$110K ﹤0.01% 5217
2026
Q1 		$121K Sell
24,702
-3,951
-14% -$21.5K ﹤0.01% 5635
2025
Q4 		$162K Buy
28,653
+7,250
+34% +$39K ﹤0.01% 5508
2025
Q3 		$109K Sell
21,403
-46,490
-68% -$269K ﹤0.01% 5496
2025
Q2 		$344K Buy
+67,893
New +$349K ﹤0.01% 4681
2025
Q1 		– Sell
-10,703
Closed -$92.9K – 5373
2024
Q4 		$92.9K Buy
+10,703
New +$63.2K ﹤0.01% 5006

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LPL Financial's CADL Position: Q2 2026 in Review

LPL Financial increased its Candel Therapeutics (CADL) stake by 59% in Q2 2026, buying an estimated $110K and bringing the position to 39,227 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #5217.

LPL Financial first reported a position in CADL in Q4 2024 and has held it in 6 quarters since. 138 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • LPL Financial held 39,227 shares of Candel Therapeutics worth $404K as of Q2 2026.
  • LPL Financial bought 14,525 Candel Therapeutics shares in Q2 2026, an estimated $110K.
  • Candel Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5217 holding.
  • LPL Financial first reported a position in Candel Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 138 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.